| __timestamp | Takeda Pharmaceutical Company Limited | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 520990000000 | 54823000000 |
| Thursday, January 1, 2015 | 535405000000 | 76585000000 |
| Friday, January 1, 2016 | 558755000000 | 87477000000 |
| Sunday, January 1, 2017 | 495921000000 | 89052000000 |
| Monday, January 1, 2018 | 659690000000 | 100745000000 |
| Tuesday, January 1, 2019 | 1089764000000 | 91915000000 |
| Wednesday, January 1, 2020 | 994308000000 | 95905000000 |
| Friday, January 1, 2021 | 1106846000000 | 104442000000 |
| Saturday, January 1, 2022 | 1244072000000 | 104437000000 |
| Sunday, January 1, 2023 | 1431505000000 | 112009000000 |
| Monday, January 1, 2024 | 1431505000000 | 121134000000 |
In pursuit of knowledge
In the ever-evolving landscape of global pharmaceuticals and retail, cost efficiency remains a pivotal factor for success. Over the past decade, Takeda Pharmaceutical Company Limited and Walgreens Boots Alliance, Inc. have showcased contrasting trajectories in their cost of revenue. From 2014 to 2024, Takeda's cost of revenue surged by approximately 175%, reflecting its expansive growth strategy and increased operational scale. In contrast, Walgreens experienced a more modest increase of around 121%, indicative of its steady yet cautious approach in the competitive retail sector.
Takeda's cost efficiency peaked in 2023, with a notable 15% rise from the previous year, while Walgreens maintained a consistent growth pattern, highlighting its resilience amidst market fluctuations. This comparison not only underscores the diverse strategies of these industry giants but also offers insights into their operational priorities and market positioning.
Cost of Revenue Trends: Johnson & Johnson vs Walgreens Boots Alliance, Inc.
Comparing Cost of Revenue Efficiency: Bristol-Myers Squibb Company vs Walgreens Boots Alliance, Inc.
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Walgreens Boots Alliance, Inc.
Analyzing Cost of Revenue: Takeda Pharmaceutical Company Limited and Cytokinetics, Incorporated
Cost of Revenue Trends: Takeda Pharmaceutical Company Limited vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Bio-Techne Corporation vs Walgreens Boots Alliance, Inc.
Cost of Revenue Trends: Walgreens Boots Alliance, Inc. vs Amneal Pharmaceuticals, Inc.
Walgreens Boots Alliance, Inc. vs Xenon Pharmaceuticals Inc.: Efficiency in Cost of Revenue Explored
Walgreens Boots Alliance, Inc. vs ADMA Biologics, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Walgreens Boots Alliance, Inc. and Vericel Corporation's Expenses
Cost of Revenue: Key Insights for Walgreens Boots Alliance, Inc. and Travere Therapeutics, Inc.